TD Waterhouse Canada’s Aurinia Pharmaceuticals AUPH Stock Holding History

TD Waterhouse Canada’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.35K	Buy	275 +94	+52%	+$1.5K	﹤0.01%	2019
2026 Q1	$2.79K	Buy	181 +161	+805%	+$2.35K	﹤0.01%	2005
2025 Q4	$319	Hold	20	–	–	﹤0.01%	1922
2025 Q3	$229	Hold	20	–	–	﹤0.01%	1962
2025 Q2	$149	Hold	20	–	–	﹤0.01%	1895
2025 Q1	$160	Hold	20	–	–	﹤0.01%	1849
2024 Q4	$180	Hold	20	–	–	﹤0.01%	1862
2024 Q3	$145	Hold	20	–	–	﹤0.01%	1802
2024 Q2	$110	Buy	+20	New	+$105	﹤0.01%	1832
2024 Q1	–	Sell	-20	Closed	-$220	–	1786
2023 Q4	$220	Hold	20	–	–	﹤0.01%	1628
2023 Q3	$203	Hold	20	–	–	﹤0.01%	1644
2023 Q2	$257	Sell	20 -550	-96%	-$5.71K	﹤0.01%	1677
2023 Q1	$7.92K	Buy	570 +550	+2,750%	+$4.85K	﹤0.01%	1270
2022 Q4	$162	Hold	20	–	–	﹤0.01%	1654
2022 Q3	$201	Hold	20	–	–	﹤0.01%	1660
2022 Q2	$294	Hold	20	–	–	﹤0.01%	1686
2022 Q1	$315	Hold	20	–	–	﹤0.01%	1724
2021 Q4	$566	Buy	+20	New	+$474	﹤0.01%	1681

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Waterhouse Canada's AUPH Position: Q2 2026 in Review

TD Waterhouse Canada increased its Aurinia Pharmaceuticals (AUPH) stake by 52% in Q2 2026, buying an estimated $1.5K and bringing the position to 275 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

TD Waterhouse Canada first reported a position in AUPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.92K in Q1 2023. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

TD Waterhouse Canada held 275 shares of Aurinia Pharmaceuticals worth $4.35K as of Q2 2026.
TD Waterhouse Canada bought 94 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $1.5K.
Aurinia Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2019 holding.
TD Waterhouse Canada first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
TD Waterhouse Canada's Aurinia Pharmaceuticals position peaked at $7.92K in Q1 2023.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.